About this Journal Submit a Manuscript Table of Contents
Journal of Cancer Epidemiology
Volume 2012 (2012), Article ID 915610, 5 pages
http://dx.doi.org/10.1155/2012/915610
Review Article

Epidemiology of Breast Cancer in Europe and Africa

1Institute of Medical Education, Cardiff University School of Medicine, 5th Floor, Cochrane Building, Heath Park, Cardiff CF14 4XW, UK
2Division of General Surgery, Department of Surgery, University of Ilorin Teaching Hospital, Ilorin 240001, Nigeria

Received 29 September 2011; Revised 19 February 2012; Accepted 11 March 2012

Academic Editor: P. Vineis

Copyright © 2012 Ganiy Opeyemi Abdulrahman Jnr. and Ganiyu Adebisi Rahman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide. IARC Cancerbase No, 10,” International Agency for Research on Cancer, Lyon, France, 2010, http://globocan.iarc.fr/.
  2. R. M. Mayberry and C. Stoddard-Wright, “Breast cancer risk factors among black women and white women: Similarities and differences,” American Journal of Epidemiology, vol. 136, no. 12, pp. 1445–1456, 1993. View at Scopus
  3. L. Fejerman, I. Romieu, E. M. John et al., “European ancestry is positively associated with breast cancer risk in Mexican women,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 4, pp. 1074–1082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. R. K. Adesunkanmi, O. O. Lawal, K. A. Adelusola, and M. A. Durosimi, “The severity, outcome and challenges of breast cancer in Nigeria,” Breast, vol. 15, no. 3, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. F. Rambau, P. L. Chalya, M. M. Manyama, and K. J. Jackson, “Pathological features of Breast Cancer seen in Northwestern Tanzania: A nine years retrospective study,” BMC Research Notes, p. 214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Public Health Wales NHS Trust, “WCISU Annual Publication No. SA10/01: Cancer Incidence in Wales 2004–2008,” Welsh Cancer Intelligence and Surveillance Unit, Cardiff, UK, 2010, http://www.wales.nhs.uk/sites3/Documents/242/incpub2010.pdf.
  7. Cancer Registry of Norway, Cancer in Norway: Cancer in Norway 2009 – Cancer incidence, mortality, survival and prevalence in Norway, Cancer Registry of Norway, Oslo, Norway, 2011.
  8. Finnish Cancer Registry, Cancer stat fact sheets, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland, 2011.
  9. R. L. Bowen, S. W. Duffy, D. A. Ryan, I. R. Hart, and J. L. Jones, “Early onset of breast cancer in a group of British black women,” British Journal of Cancer, vol. 98, no. 2, pp. 277–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Elmore, V. M. Moceri, D. Carter, and E. B. Larson, “Breast carcinoma tumor characteristics in black and white women,” Cancer, vol. 83, no. 12, pp. 2509–2515, 1998.
  11. L. A. G. Reis, C. L. Kosary, B. F. Hankey, B. A. Miller, L. X. Clegg, and B. K. Edwards, SEER Cancer Statistics Review, 1973–1996, National Cancer Institute, Bethesda, Md, USA, 1999.
  12. Q. Gao, S. Neuhausen, S. Cummings, M. Luce, and O. I. Olopade, “Recurrent germ-line BRCA1 mutations in extended african american families with early-onset breast cancer [1],” American Journal of Human Genetics, vol. 60, no. 5, pp. 1233–1236, 1997. View at Scopus
  13. S. P. Pinheiro, M. D. Holmes, M. N. Pollak, R. L. Barbieri, and S. E. Hankinson, “Racial differences in premenopausal endogenous hormones,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 9, pp. 2147–2153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Key, P. Appleby, I. Barnes, G. Reeves, and Endogenous Hormones and Breast Cancer Collaborative Group, “Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies,” Journal of the National Cancer Institute, vol. 94, no. 8, pp. 606–616, 2002.
  15. C. A. Haiman, M. C. Pike, L. Bernstein et al., “Ethnic differences in ovulatory function in nulliparous women,” British Journal of Cancer, vol. 86, no. 3, pp. 367–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson, “Racial/ethnic differences in postmenopausal endogenous hormones: the Multiethnic Cohort Study,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 10, pp. 1849–1855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. E. Boder, F. B. E. Abdalla, M. A. Elfageih, A. Abusaa, A. Buhmeida, and Y. Collan, “Breast cancer patients in Libya: comparison with European and central African patients,” Oncology Letters, vol. 2, no. 2, pp. 323–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. O. F. Ikpatt, P. Kronqvist, T. Kuopio, R. Ndoma-Egba, and Y. Collan, “Histopathology of breast cancer in different populations: Comparative analysis for Finland and Africa,” Electronic Journal of Pathology and Histology, vol. 8, no. 4, pp. 24011–24018, 2002. View at Scopus
  19. V. W. Chen, P. Correa, R. J. Kurman et al., “Histological characteristics of breast carcinoma in blacks and whites,” Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 2, pp. 127–135, 1994. View at Scopus
  20. H. Aziz, F. Hussain, C. Sohn et al., “Early onset of breast carcinoma in African American women with poor prognostic factors,” American Journal of Clinical Oncology, vol. 22, no. 5, pp. 436–440, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Newman and A. E. Alfonso, “Age-related differences in breast cancer stage at diagnosis between black and white patients in an urban community hospital,” Annals of Surgical Oncology, vol. 4, no. 8, pp. 655–662, 1997. View at Scopus
  22. L. A. Carey, C. M. Perou, C. A. Livasy et al., “Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study,” Journal of the American Medical Association, vol. 295, no. 21, pp. 2492–2502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Grosclaude, M. Colonna, G. Hedelin et al., “Survival of women with breast cancer in France: variation with age, stage and treatment,” Breast Cancer Research and Treatment, vol. 70, no. 2, pp. 137–143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Loman, O. Johannsson, U. Kristoffersson, H. Olsson, and Å. Borg, “Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer,” Journal of the National Cancer Institute, vol. 93, no. 16, pp. 1215–1223, 2001. View at Scopus
  25. C. M. Steel, “BRCA1 and BRCA2 mutations in Scotland and Northern Ireland,” British Journal of Cancer, vol. 88, no. 8, pp. 1256–1262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Bȩbenek, M. Pudełko, and J. Błaszczyk, “Breast cancer incidence and mortality in Lower Silesia (Poland) between 1984 and 2003—trends and perspectives,” Central European Journal of Medicine, vol. 2, no. 2, pp. 208–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Fregene and L. A. Newman, “Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women?” Cancer, vol. 103, no. 8, pp. 1540–1550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. G. Haffty, A. Silber, E. Matloff, J. Chung, and D. Lannin, “Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women,” Journal of Medical Genetics, vol. 43, no. 2, pp. 133–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. E. E. Marsh, N. D. Shaw, K. M. Klingman, et al., “Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women,” Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 10, pp. 3199–3206, 2011.
  30. Cancer Research UK, “Breast cancer screening,” Cancer Research UK, London, UK, 2011 http://info.cancerresearchuk.org/spotcancerearly/screening/breastcancerscreening/.
  31. National Collaborating Centre for Primary Care, “Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care,” National Institute of Clinical Excellence, London, UK, 2006 http://www.nice.org.uk/nicemedia/live/10994/30247/30247.pdf.
  32. G. A. Rahman, “Breast conserving therapy: a surgical technique where little can mean more,” Journal of Surgical Technique and Case Report, vol. 3, no. 1, pp. 1–4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Cutuli, C. Lemanski, A. Fourquet et al., “Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience,” British Journal of Cancer, vol. 100, no. 7, pp. 1048–1054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Dodwell, K. Clements, G. Lawrence et al., “Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: Indications and utilisation in the UK. Interim findings from the Sloane Project,” British Journal of Cancer, vol. 97, no. 6, pp. 725–729, 2007. View at Publisher · View at Google Scholar · View at Scopus